Day: January 12, 2021

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Oslo, 12 January 2021Reference is made to the stock exchange notices by Saga Pure ASA (the “Company“); on 14 December 2020 regarding a completed private placement of 35,000,000 new shares (“Private Placement I“), (ii) on 21 December 2020 regarding a completed private placement of 30,000,000 new shares (“Private Placement II“), and (iii) on 29 December 2020 regarding a private placement of 30,000,000 new shares (“Private Placement III” and together with Private Placement I and Private...

IKKE MENT FOR OFFENTLIGGJØRING, PUBLISERING ELLER DISTRIBUSJON, HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I ELLER TIL USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, ELLER ENHVER ANNEN JURISDIKSJON DER OFFENTLIGGJØRINGEN, PUBLISERINGEN ELLER DISTRIBUSJONEN VIL VÆRE ULOVLIG.Oslo, 12. januar 2021Det vises til børsmeldinger fra Saga Pure ASA (“Selskapet“); (i) den 14. desember 2020 vedrørende en gjennomført rettet emisjon av 35 000 000 nye aksjer (“Rettet Emisjon I“), (ii) den 21. desember 2020 vedrørende en gjennomført rettet emisjon av 30 000 000 nye aksjer (“Rettet Emisjon II“), og (iii) den 29. desember 2020 vedrørende en gjennomført rettet emisjon av 30 000 000 nye aksjer (“Rettet Emisjon III, og sammen med Rettet Emisjon I og Rettet Emisjon II, de “Rettede Emisjonene“). Det vises også...

NEW YORK, NY, Jan. 12, 2021 (GLOBE NEWSWIRE) — Global Synergy Acquisition Corp. (Nasdaq: GSAQU) (“GSAC” or the “Company”) announced today the closing of its initial public offering (“IPO”) of 25,875,000 units, including 3,375,000 units issued to the underwriters upon the full exercise of their over-allotment option, at a price to the public of $10.00 per unit. The units began trading on The Nasdaq Capital Market (“Nasdaq”) under the symbol “GSACU” on January 8, 2021. Each unit issued in the IPO consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one share of Class A common stock at $11.50 per share upon the consummation of an initial business combination. Once the securities comprising the units begin trading, the Class A common stock...

New York, Jan. 12, 2021 (GLOBE NEWSWIRE) — Kairos Acquisition Corp. (the “Company”) today announced that it closed the issuance of an additional 3,600,000 units pursuant to the exercise of the underwriters’ option in full to purchase additional units in connection with its initial public offering at $10.00 per unit, resulting in gross proceeds of $36,000,000 and bringing the total gross proceeds of the initial public offering to $276,000,000.Kairos Acquisition Corp. is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on regulated insurance or reinsurance companies, distributors...

UTRECHT, Pays-Bas, et CAMBRIDGE, Massachusetts, 12 janv. 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS) (« Merus », la « Société », « nous » ou « notre/nos »), une société d’oncologie de stade clinique qui développe des anticorps multispécifiques pleine longueur innovants (Biclonics® et Triclonics™), a annoncé que les données cliniques issues de l’étude de phase 1 avec augmentation des doses sur le MCLA-158 seront présentées lors d’une session d’affichage à l’occasion de l’assemblée générale annuelle du Symposium sur les cancers gastro-intestinaux 2021 de l’American Society of Clinical Oncology (ASCO) qui se tiendra virtuellement du 15 au 17 janvier 2021.« Nous sommes ravis que le traitement avec le MCLA-158 ait été bien toléré chez les patients, et d’avoir atteint la dose de phase 2...

UTRECHT, Niederlande und CAMBRIDGE, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) — Merus N.V.(Nasdaq: MRUS) („Merus“, „das Unternehmen“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische volllange Antikörper (Biclonics® und Triclonics™) entwickelt, hat heute bekannt gegeben, dass es klinische Daten seiner Dosiseskalationsstudie der Phase I für MCLA-158 in einer Poster-Präsentation auf dem „2021 Gastrointestinal Cancers Symposium“ (ASCO GI) der American Society of Clinical Oncology (ASCO) vorstellen wird. Die jährliche Versammlung findet vom 15. bis 17. Januar 2021 virtuell statt.„Wir freuen uns, dass die MCLA-158-Behandlung bei Patienten gut verträglich war und dass wir die empfohlene Dosis für Phase II erreicht haben“, so Andrew Joe, MD, Chief Medical Officer von Merus.„Die...

SANTA CLARA, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — A new era of laptops begins today featuring the NVIDIA Ampere architecture, with the launch of 70+ models powered by GeForce® RTX™ 30 Series Laptop GPUs.These next-gen laptops, which start at $999, increase energy efficiency by up to 2x, accelerate performance dramatically and introduce third-generation Max-Q technologies for thin and lightweight designs.The new RTX 30 Series Laptop GPUs deliver stunning ray-traced gaming experiences in Cyberpunk 2077 and other top titles, and enable content creators to produce incredible work using hundreds of GPU-accelerated apps.“After taking the desktop market by storm, our NVIDIA Ampere architecture is now powering the world’s fastest laptops,” said Kaustubh Sanghani, vice president and general manager of GeForce OEM at NVIDIA. “Nowhere...

SANTA CLARA, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — NVIDIA today announced that it is bringing the NVIDIA Ampere architecture to millions more PC gamers with the new GeForce® RTX™ 3060 GPU.With its efficient, high-performance architecture and the second generation of NVIDIA RTX™, the RTX 3060 brings amazing hardware ray-tracing capabilities and support for NVIDIA DLSS and other technologies, and is priced at $329.NVIDIA’s 60-class GPUs have traditionally been the single most popular cards for gamers on Steam, with the GTX 1060 long at the top of the GPU gaming charts since its introduction in 2016. An estimated 90 percent of GeForce gamers currently play with a GTX-class GPU.“There’s unstoppable momentum behind ray tracing, which has quickly redefined the new standard of gaming,” said Matt Wuebbling, vice president of global GeForce...

Almere, The NetherlandsJanuary 12, 2021, 6:30 p.m. CETThe Supervisory Board of ASM International N.V. (Euronext Amsterdam: ASM) today announced the nomination of Mr. P (Paul) A.H. Verhagen as CFO and Member of the Management Board of ASMI, succeeding Peter van Bommel.Mr. Verhagen (54) has a proven track record and background in Dutch listed companies. He has made a career within Royal Philips starting in the early nineties and fulfilled until 2013 numerous executive positions in the Netherlands, the USA, Hong Kong, and China. His last two assignments, from 2007 until 2013, were as Executive Vice President and CFO of Philips Consumer Lifestyle, and Executive Vice President and CFO of Philips Lighting. Since 2014 he is the CFO and Member of the Management Board of the Dutch stock listed company Fugro N.V. Mr. Verhagen is a Dutch national...

Charenton-le-Pont, January 12, 2021Update on the formalization of the agreement in principle on the amendment of the Scotch Whisky supply contractUpdate on the proposed Capital IncreaseMarie Brizard Wine & Spirits (Euronext: MBWS) announces today that after lengthy discussions, an agreement has finally been formalized between the Company and its main bulk supplier of Scotch Whisky and that the parties have signed the amended contract today, after prior authorization by the Board of Directors.The main effect of this new contract is to reset the Group’s minimum annual volume purchase commitments compared with those provided for in 2021 and subsequent years under the terms of the previous contract. To date, these purchase commitments represent virtually all of the Group’s Scotch Whisky supply requirements for its William...